A feeding-tube robot aims at the 3% to 5% of placements that end up in the lungs

ENvue Medical detailed ENvue Drive on 28 July 2026: robotic assistance combining electromagnetic navigation, AI software and real-time guidance to steer a feeding tube through the nose into the small intestine, identifying anatomical pathways, detecting trajectory deviations and offering corrective guidance while the clinician keeps control throughout. The company puts current misplacement at about 3% to 5% of procedures, landing in the lungs, which it says can collapse a lung or fill it with fluid. The underlying ENvue Navigation Platform is 510(k) FDA-cleared; the robotic system is not, and the company says it will pursue additional clearances in the coming years.

What it means A clean example of the assistive framing that clears regulators: the robot narrows the error band, the clinician keeps the hands.